Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis

依普利酮 医学 内科学 微量白蛋白尿 肾功能 科克伦图书馆 随机对照试验 螺内酯 糖尿病肾病 胃肠病学 肾脏疾病 糖尿病 肌酐 内分泌学 心力衰竭
作者
Honglei Hu,Xiaodong Zhao,Xingqian Jin,Shujuan Wang,Wenlong Liang,Xiangguo Cong
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:17 (3): e0265642-e0265642 被引量:12
标识
DOI:10.1371/journal.pone.0265642
摘要

Diabetic nephropathy (DN), which is correlated with an increased risk of cardiovascular disease, significantly elevates the morbidity and mortality of patients with diabetes. Recently, the benefits of mineralocorticoid receptor antagonists in chronic kidney disease (CKD), such as their anti-inflammatory and anti-fibrotic properties, have been discovered. Thus, the present meta-analysis aimed to systematically assess the efficacy and safety of eplerenone treatment in patients with DN. Six electronic databases-PubMed, The Cochrane Library, Embase, Web of Science, CNKI (China National Knowledge Infrastructure), and CBM(Chinese BioMedical Literature Database)-were searched to retrieve randomized controlled trials that assessed eplerenone treatment in patients with DN and were published up to July 31, 2021. Eight randomized controlled trials involving 838 patients were included. Between the eplerenone treatment groups and controls, significant differences were identified in 24-h urine protein levels (mean difference [MD], -19.63 [95% CI, -23.73 to -15.53], P < 0.00001), microalbuminuria (MD, -7.75 [95% CI, -9.75 to -5.75], P < 0.00001), urinary albumin-creatinine ratio (MD, -48.29 [95% CI, -64.45 to -32.14], P < 0.00001), systolic blood pressure (SBP) (MD, -2.49 [95% CI, -4.48 to -0.50], P = 0.01), serum potassium levels (MD, 0.19 [95% CI, 0.13 to 0.24], P < 0.00001), and levels of the renal fibrosis indicator laminin (MD, -8.84 [95% CI, -11.93 to -5.75], P < 0.00001). However, for the effect of estimated glomerular filtration rate (MD, 1.74 [95% CI, -0.87 to 4.35], P = 0.19) and diastolic blood pressure (MD, -0.51 [95% CI, -1.58 to 0.57], P = 0.36), the differences between the two groups were not significant. In addition, no noticeable difference was identified in the adverse events of hyperkalemia and cough between them. These findings suggest that eplerenone exerts beneficial effects on DN by significantly reducing urinary albumin or protein excretion, SBP, and laminin levels, without increasing the incidence of hyperkalemia and other adverse events.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
猪美丽发布了新的文献求助100
1秒前
舒心的青亦完成签到 ,获得积分10
2秒前
2秒前
chen完成签到,获得积分10
3秒前
清新的易真完成签到,获得积分10
3秒前
123123完成签到 ,获得积分10
4秒前
量子星尘发布了新的文献求助10
4秒前
HongJiang完成签到,获得积分10
4秒前
table完成签到,获得积分10
4秒前
lightman完成签到,获得积分10
5秒前
hdx完成签到 ,获得积分10
6秒前
leaf完成签到 ,获得积分10
7秒前
TT发布了新的文献求助10
8秒前
橙果果完成签到,获得积分10
10秒前
酷炫橘子完成签到,获得积分10
10秒前
柒柒球完成签到,获得积分10
11秒前
Wang完成签到,获得积分10
11秒前
赖雅绿完成签到,获得积分10
12秒前
Smile:)发布了新的文献求助10
12秒前
李十一完成签到,获得积分10
13秒前
科研修沟完成签到 ,获得积分10
13秒前
14秒前
14秒前
赵雨霏完成签到 ,获得积分10
15秒前
NB完成签到,获得积分10
15秒前
meng完成签到,获得积分10
16秒前
虫虫完成签到,获得积分10
17秒前
JingP完成签到,获得积分10
18秒前
18秒前
lsl完成签到 ,获得积分10
18秒前
19秒前
zxp发布了新的文献求助10
20秒前
读书的时候完成签到,获得积分10
22秒前
crave发布了新的文献求助10
23秒前
贵贵完成签到,获得积分10
24秒前
Lz完成签到,获得积分10
25秒前
玩命的寄翠完成签到 ,获得积分10
26秒前
潘道士完成签到 ,获得积分10
27秒前
曾建完成签到 ,获得积分10
27秒前
Sonder完成签到 ,获得积分10
28秒前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Social Research Methods (4th Edition) by Maggie Walter (2019) 2390
A new approach to the extrapolation of accelerated life test data 1000
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
Atlas of Interventional Pain Management 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4008920
求助须知:如何正确求助?哪些是违规求助? 3548597
关于积分的说明 11299259
捐赠科研通 3283208
什么是DOI,文献DOI怎么找? 1810293
邀请新用户注册赠送积分活动 886005
科研通“疑难数据库(出版商)”最低求助积分说明 811259